World Institute of Pain

WIP-Endorsed Practice Advisory for Contrast Agents in Interventional Pain Procedures

March 26, 2021

Just published: The Use of Contrast Agents in Interventional Pain Procedures: A Multispecialty and Multisociety Practice Advisory on Nephrogenic Systemic Fibrosis, Gadolinium Deposition in the Brain, Encephalopathy After Unintentional Intrathecal Gadolinium Injection, and Hypersensitivity Reactions.  Read more…

The World Institute of Pain® is exempt from federal income tax under section 501(a) of the Internal Revenue Code as an
organization described in section 501(c)(3).

Federal ID No. 95‐4579119